|
Volumn 85, Issue , 2014, Pages 359-370
|
Design, synthesis and biological evaluation of 17-arylmethylamine-17- demethoxygeldanamycin derivatives as potent Hsp90 inhibitors
|
Author keywords
Antitumor activities; Geldanamycin; Hepatotoxicity; Hsp90; Molecular dynamics
|
Indexed keywords
17 (2 CHLOROBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (2 METHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (2 METHYLBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (2,4 DIMETHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3 AMINOBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3 CHLOROBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3 CYANOBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3 METHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3 METHYLBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3,4 DIFLUOROBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3,4 DIMETHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3,4,5 TRIMETHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (3,5 DIFLUOROBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 AMINOBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 BROMOBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 CHLOROBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 CYANOBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 FLUOROBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 HYDROXY 3 METHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 HYDROXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 IODOBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 METHOXYBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 METHYLBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 METHYLSULFONYLBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
17 (4 SULFAMOYLBENZYLAMINO) 17 DEMETHOXYGELDANAMYCIN;
ANTINEOPLASTIC AGENT;
GELDANAMYCIN;
HEAT SHOCK PROTEIN 90 INHIBITOR;
TANESPIMYCIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
17 (3,5 DIFLUOROBENZYLAMINO)-17 DEMETHOXYGELDANAMYCIN;
17 ARYLMETHYLAMINE 17 DEMETHOXYGELDANAMYCIN DERIVATIVE;
ALVESPIMYCIN;
BENZOQUINONE DERIVATIVE;
HEAT SHOCK PROTEIN 90;
MACROCYCLIC LACTAM;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
CANCER CELL LINE;
CONTROLLED STUDY;
CYTOTOXICITY;
DOWN REGULATION;
DRUG DESIGN;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
LIVER TOXICITY;
LNCAP CELL LINE;
MOLECULAR DYNAMICS;
MOUSE;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
THEORETICAL MODEL;
TOXICITY TESTING;
TUMOR XENOGRAFT;
WESTERN BLOTTING;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
DRUG CYTOTOXICITY;
IC50;
MALE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CELL PROLIFERATION;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG EFFECTS;
LIVER;
PROTEIN CONFORMATION;
SYNTHESIS;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZOQUINONES;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CHEMISTRY TECHNIQUES, SYNTHETIC;
DRUG DESIGN;
HSP90 HEAT-SHOCK PROTEINS;
HUMANS;
LACTAMS, MACROCYCLIC;
LIVER;
MALE;
MICE;
MODELS, MOLECULAR;
PROTEIN CONFORMATION;
|
EID: 84905705083
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2014.07.101 Document Type: Article |
Times cited : (21)
|
References (37)
|